News in the Life Sciences Industry

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- Enzymatica and MS Pharma, with headquarters in Amman, Jordan, have entered an agreement for marketing, distribution and sales of Enzymatica's common cold spray ColdZyme® in MENA - Middle East and North Africa. The agreement covers Saudi Arabia, Jordan,... Read more ››

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- "On August 13(th), we announced a EUR19.8m acquisition of a majority stake of 62.7% in Genkyotex, a publicly listed life science company in France. We are very excited about this acquisition, which complements our existing and long-standing focus on inflammatory... Read more ››

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- Cantargia AB's ("Cantargia") interim report for the period January until September 2020 is now available on the company's web page Read more ››

LINKÖPING, Sweden, Nov. 12, 2020 /PRNewswire/ -- The international medical imaging IT and cybersecurity company Sectra (STO:... Read more ››

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- NeoDynamics AB (publ), (Spotlight Stockholm: NEOD), today announced that the Company joins in a research collaboration with the William Hunter Revisited research consortium to evaluate NeoNavia pulse biopsy system for joint tissue sampling in a new... Read more ››

STOCKHOLM, Nov. 12, 2020 /PRNewswire/ -- January 1 - September 30, 2020

BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for in Asia 2020 Award' by HR Asia on 16(th) October 2020.

LUND, Sweden, Nov. 11, 2020 /PRNewswire/ -- The Nomination Committee, which is to be appointed for the period until a new Nomination Committee is appointed, shall consist of four members, of which three will be appointed by the Company's three largest shareholders in terms of voting, and the... Read more ››

STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- Implantica AG (publ) today announced the three-year follow-up results of their medical implant RefluxStop™. After three years, results were remarkable; none of the 47 patients in the study were in need of regular daily use of PPIs (proton-pump inhibitors),... Read more ››

LINKÖPING, Sweden, Nov. 11, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a... Read more ››

STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) ("AlzeCure"), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced... Read more ››

STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR) ("AlzeCure"), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today... Read more ››

STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- On November 12, 2020, at 07:00 am CET, Calliditas Therapeutics ("Calliditas") will publish its business update for the third quarter 2020. Calliditas will also host a telephone conference, which will include a presentation of the results, on the same day... Read more ››

LUND, Sweden, Nov. 11, 2020 /PRNewswire/ -- The Nomination Committee, which is to be appointed for the period until a new Nomination Committee is appointed, shall consist of four members, of which three will be appointed by the Company's three largest shareholders in terms of voting, and the... Read more ››

STOCKHOLM, Nov. 11, 2020 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION... Read more ››

STOCKHOLM, Nov. 10, 2020 /PRNewswire/ -- Cyxone (publ.) announced today that the company has filed for an extended patent protection of Rabeximod with the European Patent Office (EPO), that will be extended to other territories in due course. An approval of the application will strengthen... Read more ››

LONDON, Nov. 10, 2020 /PRNewswire/ -- LumiraDx, the next generation point-of-care diagnostic company, announced today a $32 million... Read more ››